Onsdag 28 Oktober | 21:09:27 Europe / Stockholm

All ägardata du vill ha finns i Holdings!

Annexin Q2’23 - Eventful period ahead

2023-08-04 18:25:00

Redeye returns with an update following Annexin’s Q2 report. We note that the quarter was relatively uneventful but look forward to more newsflow in H2, most notably phase II RVO-data and a financing solution. We reiterate our base case for now.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/